As Emergent BioSolutions continues to pawn off manufacturing real estate in its pivot from production specialist to full-time ...

Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit that the Swiss pharma ...

Shortly after Starboard Value pitched four nominees for Kenvue's | Activist investor Starboard Value proposed four additions ...

Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. | Three ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

In a statement, Trotter described his experience as a child with older relatives who struggled with Type 2 diabetes. Trotter ...

Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...

Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...

| Real-world evidence lets us see how HIV medicines work in real life, helping HCPs provide better care and improving ...

By Andrew Gottfried, Chief Executive Officer, Nexus Health Group | As the US healthcare landscape continues to evolve, 2025 is set to bring significant transformations driven by shifting policies, ...